ArticlePulmonary circulation2024

Delta-like ligand 4 inhibitor drug treatment induces pulmonary hypertension in cancer clinical trials.

Casandra E Besse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.